A download link will be emailed after check out.
Opdivo (nivolumab) in combination with Yervoy (ipilimumab) is used to treat bowel cancer, that is shown by a laboratory test to have certain biological markers (microsatellite instability-high (MSI-H) or mismatch repair deficient (dMMR).
Opdivo and Yervoy are proteins which help your immune system to attack and destroy cancer cells.
